Cambridge Major Laboratories, Inc. Adds Significant Capacity at U.S. Site

Published: Sep 10, 2012

GERMANTOWN, Wis.--(BUSINESS WIRE)--Following continued growth in demand for larger scale Active Pharmaceutical Ingredient (API) manufacturing services, Cambridge Major Laboratories (CML) is announcing a significant expansion of its large scale API manufacturing facility in Germantown, Wisconsin. The expansion comes only three years after commissioning the new state-of-the-art facility, further validating CML’s business model of focused investment in US-based assets.

Back to news